The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Immunotherapy question

MandiePandie
MandiePandie CSN Member Posts: 109 Member
in Colorectal Cancer #1

So do they try immunotherapy for anyone who is MSS? I was looking up trials the other day and they all had to do with mutations or MSI (of which my dad does not have). From what I understand being MSI or having mutations is more rare so I'm just wondering why so many trials? I mean, of course if it means cures for those people that is great. Maybe I'm misunderstanding the whole thing anyway :/

Like Care

Comments

  • SnapDragon2
    SnapDragon2 CSN Member Posts: 732 Member
    #2
    I found the book "The

    I found the book "The Immunotherapy Revolution" by Dr. Jason Williams an interesting read.

    Like Care
  • Real Tar Heel
    Real Tar Heel CSN Member Posts: 307 Member
    edited May 2021 #3
    There is a study with MSS

    There is a study with MSS patients with a high number of mutations present who are treated with Keytruda, they have had some success, so you would expect some money to go there. However, I think the pharma companies are putting their money behind mRNA targeted therapy for MSS tumors, however. That's a sign of the confidence they have in the tech, unless these docs are great salespersons. It's probably more the speed with which docs were able to come up with a COVID vaccine using mRNA therapy that is turning heads.

     

    Like Care
  • abita
    abita CSN Member Posts: 1,152 Member
    edited May 2021 #4
    Real Tar Heel said:

    There is a study with MSS

    There is a study with MSS patients with a high number of mutations present who are treated with Keytruda, they have had some success, so you would expect some money to go there. However, I think the pharma companies are putting their money behind mRNA targeted therapy for MSS tumors, however. That's a sign of the confidence they have in the tech, unless these docs are great salespersons. It's probably more the speed with which docs were able to come up with a COVID vaccine using mRNA therapy that is turning heads.

     

    The speed had a lot to do

    The speed had a lot to do with the research into corona viruses that has been going on for years. But I do hope that this proves to be a route to the cure I have been holding on gor.

    Like Care

Discussion Boards